Laurberg, Tinne
Witte, Daniel Rinse
Gudbjörnsdottir, Soffia
Eliasson, Björn
Bjerg, Lasse
Article History
Received: 6 October 2023
Accepted: 7 May 2024
First Online: 13 May 2024
Competing interests
: D.R.W. own shares in Novo Nordisk A/S. BE reports personal fees from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp and Dohme, Mundipharma, NovoNordisk, RLS Global and Sanofi, all outside the submitted work. T.L., L.B., S.G. have no conflicts of interest.